Phase I clinical trials are the first step in testing a new treatment or combination of treatments. These trials often ...
The OCU200 Phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal injection in three cohorts: low dose (0.025 mg), medium dose (0.05 mg ...
About the Trial TransCode's Phase 1 clinical trial is a multicenter ... sponsorship packages for our investment conferences and advertising on our websites and newsletters.
Clinical trials can assist you in getting the right treatment for your condition. Before you consider it, here's what you should know.
BOSTON - TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a micro-cap RNA oncology company with a market capitalization of $6.22 million, has announced the progression of its Phase 1 clinical trial with ...
Allakos (ALLK) announced topline results from its phase 1 clinical trial of AK006 in chronic spontaneous urticaria. In the CSU cohort, 34 adult patients with moderate-to-severe CSU refractory to ...
Pyxis Oncology announces Phase 1/2 trials for PYX-201, combining it with KEYTRUDA® to treat advanced solid tumors. Pyxis Oncology, Inc. has announced the initiation of two significant clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results